baber/WOPTO huggingface dataset:
Patent NZ-265739-A (NZ)
Title: Alkaline cell with zinc anode and manganese dioxide cathode has high capacity
Inventor: NEWMAN GERALD H
IPC: H01M6/08
Filed: 1994-01-21
Abstract: The present invention is an improved alkaline cell wherein the capacity of each of the anode and cathode is at least 0.48 and more preferably to at least 0.5 ampere-hour per cm3 of internal cell volume. This is achieved by employing zinc densities of at least 1.4 grams of zinc per cm3 of anode volume and MnO2 densities of at least 2.7 grams of MnO2 per cm3 of cathode volume.
Patent NZ-268148-A (NZ)
Title: Cleaning composition with increased viscosity when diluted
Inventor: BESSE MICHAEL E
IPC: C11D1/835
Filed: 1994-04-22
Abstract: A low viscosity aqueous cleaning composition provides increasing viscosity upon dilution which provides a high viscosity diluted cleaning composition having solvents compatible with the rod micelle thickener and the cleaning system that clings for an extended period of time in a thickened form containing cleaning system ingredients that can penetrate and remove hard baked-on soils on vertical surfaces in cleaning units. The composition contains active cleaning ingredients (acid, alkaline and enzyme) that, in combination with thickening systems, provide the useful properties. The thickened materials can be applied on cold or hot surfaces and can successfully penetrate, soften and remove baked-on food soil on a variety of surfaces including oven walls, doors and grills, baking dishes, utensils, etc. The material is applied in the form of a thick diluted liquid spray or hot foam directly to the hardened soil, is permitted to penetrate the soil, resulting softened soils are then easily removed by hot or cold water rinse or by mechanical action such as scrubbing, scraping or wiping.
Patent NZ-269070-A (NZ)
Title: Use of <ital>streptomyces</ital> wyec 108 in controlling fungal infections in plants
Inventor: CRAWFORD DONALD L
IPC: A01N63/28
Filed: 1994-06-29
Abstract: This invention relates to a biocontrol formulation suitable for reducing the susceptibility of plants to fungal phytopathogens. In one aspect of the invention, a newly isolated strain of Streptomyces, Streptomyces WYEC 108, is incorporated into a suitable delivery medium and applied to plant seeds or plant roots.
Patent NZ-291056-A (NZ)
Title: Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function
Inventor: JENNINGS-WHITE CLIVE L
IPC: A61K31/56
Filed: 1995-08-04
Abstract: A pharmaceutical composition suitable for nasal administration in an individual, said composition comprising at least one steroid and a pharmaceutically acceptable carrier, wherein said at least one steroid has the formula (I) wherein, P1 is selected from the group consisting of oxo, alpha(beta)hydroxy, alpha(beta)acetoxy, alpha(beta)propionoxy, alpha(beta)methoxy, alpha(beta)lower acyloxy, alpha(beta)lower alkyloxy and alpha(beta)benzoyloxy, P2 is selected from the group consisting of methyl, hydroxymethyl, acyloxymethyl, alkoxymethyl, lower alkyl, hydroxyalkyl, acyloxyalkyl and alkoxylalkyl P3 is selected from the group consisting of hydrogen, oxo, halo, hydroxy, alkoxy and acyloxy, P4 through P12 may each be, independently, hydrogen, halo, methyl, or halo, dihalo or perhalomethyl, P13 is hydrogen, methyl, methylene, halo-substituted methyl or halo-substituted methylene, ethyl, ethylenyl, acetylenyl, methyl-methylenyl or methyl-methinyl, and "a", "b", "c", "d", "e", "h", "i", "j" and "k" are alternative sites for optional double bonds and "j" or "k" may also be triple bonds, and when P2 is methyl and P3 is beta-hydroxy, P2 and P3 may be joined to form a cyclic ether. The abovementioned composition may be used to alter the hypothalamic function of an individual.
Patent NZ-305162-A (NZ)
Title: Can clip carrier; comprises a planar unit with top and bottom support panels in face-to-face relation, both panels having support tabs, can upper portions extend through openings in the unit
Inventor: SUTHERLAND ROBERT L
IPC: B65D71/12
Filed: 1996-03-13
Abstract: A can clip carrier having support tabs on both top and bottom panels. The panels are in face-to-face contact, with the bottom panel tabs located between and in contact with the upper portion of the cans and the top panel support tabs. The bottom tabs are spaced apart a distance such that some of the top panel tabs engage the upper portion of the cans between spaced bottom panel tabs.
Patent NZ-308486-A (NZ)
Title: Process for producing caprolactam
Inventor: FUCHS EBERHARD
IPC: C07D223/12
Filed: 1996-05-07
Abstract: he production of caprolactam by reacting 6-amino capronitrile with water in the presence of catalysts, using an initial mixture of 6-amino capronitrile and the tetrahydroazepine derivative of formula (I) above, and reaction in the liquid phase in the presence of heterogeneous catalysts, and a process for producing tetrahydroazepine derivative (I) and its use for making caprolactam.  Divisional filed as 500058
Patent NZ-308898-A (NZ)
Title: Potentiation of the microbicide 2-(thiocyanomethylthio)-benzothiazole using an n-alkyl heterocyclic compound
Inventor: WHITTEMORE MARILYN S
IPC: A01N43/36
Filed: 1996-05-28
Abstract: icrobicidal compositions are described. The compositions comprise: (a) 2-(thiocyanomethylthio)benzothiazole (TCMTB) and (b) an N-alkyl heterocyclic compound of the above formula.  The variable "n" ranges from 5 to 17, and the heterocyclic ring defined by (1) is a substituted or unsubstituted ring having four to eight members.  Components (a) and (b) are present in a combined amount effective to control the growth of at least one microorganism. Methods for controlling the growth of microorganisms on various substrates or in aqueous systems are also described. Also described is the industrial application of the microbicidal composition in the leather industry, the lumber industry, the papermaking industry, the textile industry, the agricultural industry, and the coating industry, as well as in aqueous systems.  Divisional filed as 501813
Patent NZ-310559-A (NZ)
Title: Bicyclic sulphonamide and carboxamide derivatives and medicaments
Inventor: OHTANI MITSUAKI
IPC: C07D279/20
Filed: 1996-06-19
Abstract: A compound of the formula (I): <CHEM>  wherein <CHEM>  for example, a compound below: <CHEM>  wherein     R1 is CH3, H or Na; and X1-X2-X3 is <CHEM> or a salt or a hydrate thereof is useful as a PGD2 antagonist and can be used as a drug for treating diseases in which mast cell dysfunction is involved, for example, systemic mastocytosis and disorder of systemic mast cell activation, and also tracheal contraction, asthma, allergic rhinitis, allergic conjunctivitis, urticaria, injury due to ischemic reperfusion, and as an anti-inflammatory agent. It is particularly useful in the treatment of nasal occlusion.
Patent NZ-318455-A (NZ)
Title: Method for the preparation of cation exchange membranes doped with insoluble metal salts
Inventor: D AGOSTINO VINCENT F
IPC: C08J5/22
Filed: 1996-09-19
Abstract: The present invention relates to a method of preparing a modified cation exchange membrane in which a sulfide of silver, tungsten, molybdenum or a mixture thereof is deposited within the polymer matrix, which method comprises the steps: a)	forming within the polymer matrix of the membrane a complex of silver, tungsten, molybdenum or a mixture thereof with a water soluble compound containing a -SH group; and b)	converting the complex formed in step a) into the insoluble sulfide of silver, tungsten, molybdenum or a mixture thereof.
Patent NZ-319360-A (NZ)
Title: Tubing connector comprising two tubular legs and a handle extending at a right angle relative to the legs
Inventor: OSBORNE ROBERT S
IPC: A61M39/12
Filed: 1996-09-11
Abstract: A tubing connector has first and second tubular legs joined together to provide a continuous fluid pathway therethrough with the fluid pathway having a bend of about 78 to 102 degrees therein. A foreshortened retention tab extends laterally from the tubing connector at about the bend in a direction opposed to the second leg of the tubing connector. A handle extends from the tubing connector at about a right angle to both the first and second legs and the retention tab. The tubing connector may be employed as a component of a fluid delivery set used with a pump for enteral or parenteral feeding of a patient.
Patent NZ-329530-A (NZ)
Title: A method and kit for the identification of the il-1rn genetic polymorphism pattern associated with low bone mineral density in osteoporosis
Inventor: DUFF GORDON
IPC: C12Q1/68
Filed: 1997-04-03
Abstract: The present invention relates to methods of predicting the risk of osteoporosis. Specifically, the methods comprise isolating genomic DNA from an individual and determining an allelic pattern for IL-1 receptor antagonist (IL-1ra) in the genomic DNA. The identification of at least one copy of allele 2 indicates increased susceptibility to osteoporosis.
Patent NZ-331700-A (NZ)
Title: Screw fastener driving tool with relative contraction and retraction of telescoping tubes causing fasteners to be transferred from side by side magazine to nose piece
Inventor: OLVERA GILBERT
IPC: B25B21/00
Filed: 1998-09-03
Abstract: A stand-up fastener driving tool including a fastener driving member disposed within telescoping upper and lower tubes (30, 40), wherein the lower tube (30) has a nose-piece (50) with an opening (52) for retaining a fastener therein. The fastener driving member is extendable toward and away from the nose-piece (50) upon contraction and extension of the lower and upper tubes (30, 40). A plurality of fasteners are retained side by side in a magazine of the tool, and are individually releasable therefrom upon contraction and extension of the upper and lower tubes (30, 40). <IMAGE>
Patent NZ-333016-A (NZ)
Title: Transformer/reactor with windings of insulated and semiconductive screened cable
Inventor: LEIJON MATS
IPC: H02K3/14
Filed: 1997-05-27
Abstract: A power transformer/reactor (14, 15, 16) for high voltages includes at least one winding having at least one current-carrying conductor. The winding comprises a solid insulation (7) surrounded by outer and inner layers (8, 6) serving for equalization of potential and having semiconducting properties. The layers (6, 8) and the insulation (7) adhere along essentially the whole of their contact surfaces. The outer layer (8) is connected to ground or otherwise relatively low potential. The solid insulation in the windings constitutes substantially the total electrical insulation in the power transformer/reactor.
Patent NZ-333173-A (NZ)
Title: multilayer shrink film having an outer layer comprising an ethylene/alpha olefin copolymer with at least one surface having a silicone coating with ink adhesion properties
Inventor: ECOFF MARTIN J
IPC: B29C48/10
Filed: 1997-06-04
Abstract: A polymeric film having two major surfaces comprising a copolymer of ethylene and a C4-8 a-olefin wherein the two major surfaces each have a silicone containing of between 0.1 and 1.2 mg/ft2 is claimed. A process for preparing the polymeric film is also claimed.
Patent NZ-333915-A (NZ)
Title: Soluble monovalent and multivalent MHC class II fusion proteins
Inventor: STROMINGER JACK L
IPC: C07K19/00
Filed: 1997-08-15
Abstract: A Class II Major Histocompatibility Complex fusion protein comprising a fusion of, toward the N-terminus, at least a MMC Class II binding domain of an MMC Class II chain and, toward the C-terminus, a dimerization domain. The complex is useful for detecting T cells having a defined Class II MHC-peptide complex specificity, conferring adoptive immunity to a defined Class MHC-peptide complex to a subject, stimulating or activating T cells reactive to a defined Class II MHC-peptide complex, selectively killing T cells reactive to a defined Class II MHC-peptide and tolerizing a human subject to a defined Class II MHC-peptide complex .
Patent NZ-334342-A (NZ)
Title: Compounds for inhibition of farnesyl protein transferase and the treatment of cancer
Inventor: NJOROGE F GEORGE
IPC: C07D409/14
Filed: 1997-09-11
Abstract: The compounds of formula (1.0) can be used in a medicament for inhibiting farnesyl protein transferase and the growth of tumor cells.  In formula (1.0): One of a, b, c and d represents N, NO, NCH3 or N(CH2)nCO2H, and the remaining a, b, c and d groups represent CR1 or CR2; or each of a, b, c and d are independently selected from CR1 or CR2; R1 and R2 are independently selected from H, halo, CF3, OR10, COR10, SR10, CN, NR10R11, OCO2R11 or other group. R3 and R4 are the same or different, selected from H, any of the substituents of R1 and R2; or R3 and R4 taken together represent a saturated or unsaturated C5 -7 ring fused to the benzene ring (III). R5, R6, R7 and R8 are independently H, CF3, COR10, optionally substituted alkyl or aryl, or R5 with R6, and/or R7 with R8 represents  =O or =S. X is N, CH or a C which may contain an optional double bond to carbon atom 11.  When a double bond is present A and B represent R10, halo, OR11, OCO2R11 or OC(O)R10, and when no double bond is present A and B are H2, (OR11)2, halo, dihalo, alkyl, =O or other group. R10 represents H, alkyl, aryl or aralkyl and R11 represents alkyl or aryl. W represents a group selected from formulae (1) to (4), wherein; R12 is H, alkyl, aralkyl or heteroalkyl, R13 and R14 are H, C(O)OR16, (wherein R16 is alkyl, aralkyl or heteroalkyl), SO2R17, (wherein R17 is NH2, N(alkyl)2), C(O)R18 (wherein R18 is aryl, alkyl, heteroalkyl, heteroaryl or heteroaralkyl) C1-6 alkyl, alkaryl or cycloalkyl, R15 is heteroaryl, heterocycloalkyl containing N, N and O, N and S, or two O as the hetero atoms, or another group, R22 is a five membered heterocycle ring with S, N or N and O as the hetero atoms, or another group,  r is 0-2, s is 1-5, v is 0-2, z is 0-5.
Patent NZ-506388-A (NZ)
Title: Produce sizing or sorting transport mechanism with a support region of retaining members located beneath the produce being sized or sorted
Inventor: PARSONS IAN A
IPC: B65G47/61
Filed: 1999-02-22
Abstract: A transport system for use in a produce sizing or sorting apparatus has a plurality of pivotally interconnected carrier members (10) forming an endless conveyor.  Each carrier member (10) having a pair of finger members (25, 26) connected thereto in a manner whereby the finger members depend downwardly at least along a portion of the endless conveyor.  Each pair of finger members (25, 26) together with adjacent such pairs defining a produce retaining zone (22) extending in the direction of the endless conveyor when the finger members (25, 26) are positioned in a closed position, and at least one of each finger member pair (25, 26) being selectably pivotable, in use, to an open position enabling produce to be released from the produce retaining zone (22) at desired and spaced locations along the path of the endless conveyor.  The finger member pair (25, 26) defines a support region that is located at least partially beneath produce retained by the finger member pair (25, 26) when they are in the closed position.
Patent NZ-509819-A (NZ)
Title: Method and apparatus for rendering image
Inventor: AOKI SACHIYO
IPC: G06T15/04
Filed: 2000-06-15
Abstract: A normal rendering process is performed on at least one object to render an image, and the rendered image is mapped as a texture onto a provisional object (106) composed of a small number of polygons (P1, P2) and the object is rendered in an area (34b) to be displayed. When n objects, for example, are to be rendered in the display area (34b) of an image memory (34), the normal rendering process is performed on at least one of the objects to render an image, for example, in an area (A) in the display area (34b), and the image rendered in the display area (34b) is mapped as a texture onto the provisional object (106) for the remaining (n - 1) objects and the object is sequentially rendered in areas (B1 - B15) in the display area (34b).
Patent NZ-510780-A (NZ)
Title: Contactless access ticket and method for making same
Inventor: KAYANAKIS GEORGES
IPC: G07B15/00
Filed: 2000-07-07
Abstract: The method concerns a ticket providing access to a zone with controlled access when it is presented without contact in front of a scanner authorising access to the zone, said ticket having an Edmonson format and comprising a paper ticket body (12) covered on both surfaces with a protective coating. The paper ticket body (12) is provided with a through recess where within this recess is an electronic module (14) comprising an integrated circuit and an antenna. The latter is formed by at least one turn obtained by screen-printing with silvery powder in a polymerisable composition before being heat-cured. Said ticket provides the advantages of being inexpensive to produce compared to a contactless access card and is highly biodegradable, which is essential for a disposable ticket.
Patent NZ-513156-A (NZ)
Title: Transgenic plants modified to contain resveratrol glucoside and uses thereof
Inventor: HIPSKIND JOHN D
IPC: C12N15/82
Filed: 2000-01-28
Abstract: The specification relates to the use of a nontoxic, nutritionally enhanced plant material suitable for dietary or nutraceutical consumption. This plant material comprises transgenic plant cells transformed with a resveratrol synthase transgene under the control of a constitutive promoter resulting in an increased concentration of resveratrol glucoside. Progeny carrying the same genetic transformation as the parent plant are also claimed. The method for improving the nutritional value of a plant by transformation of the said gene is also included as is the cultivation of the modified plants under conditions conducive to the minimize the spoilage of the plants and the degradation of the transformed gene product.
Patent NZ-515487-A (NZ)
Title: Injection device with skin rucker portion where the skin rucker portion ruckers the patient's skin prior to needle insertion
Inventor: PLANT SHAUN
IPC: A61M5/42
Filed: 2001-11-13
Abstract: An injection device with a syringe assembly and a skin rucker (8) that is fitted to the barrel via a biasing means (9) that utilizes the pressure adjustment nut to control the movement of the skin rucker in relation to the syringe assembly. The skin rucker assembly includes an area of high coefficient of friction for contact with skin. Pressure application to the injection device causes skin rucker withdrawal against the resistance of the biasing means (9) and the needle (6) enters the rucked up animal skin (11). The distance of travel and the position of the needle in relation to the skin rucker can be altered to be located in closest proximity to the skin rucker.
Patent NZ-516810-A (NZ)
Title: Method of forming an artificial shiro of tricholoma matsutake hyphae
Inventor: SUZUKI KAZUO
IPC: A01G1/04
Filed: 2002-01-24
Abstract: A method of forming an artificial Shiro of Matsutake comprising culturing Matsutake hyphae in a culture substrate containing a substance capable of controlling the cell membrane permeability of the hyphae as an active principle.
Patent NZ-516971-A (NZ)
Title: Control for an automatic washer with spray pretreatment
Inventor: WHAH KENNETH N
IPC: D06F39/00
Filed: 2000-06-20
Abstract: This control relates a control for an automatic washer incorporating a spray pretreatment or stain care cycle. In order to manage the occurrence of the condition of suds lock, the state of the washing machine related to the suds lock condition during spray pretreatment is determined by one or more of a number of methods. With this information concerning the state of the spray pretreatment process, the occurrence of suds lock can be ascertained and the cycle can be controlled accordingly to minimize negative effects resulting from a prolonged suds lock condition. Additionally, with certain information related to the occurrence of suds lock, steps can be taken during the spray pretreatment portion of the cycle to avoid the condition of suds lock altogether. Using the same primary process for measuring suds lock, load size can also be ascertained. Information about load size can be used to control the wash cycle.
Patent NZ-522967-A (NZ)
Title: 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors
Inventor: CARRY JEAN-CHRISTOPHE
IPC: A61P31/04
Filed: 2001-06-07
Abstract: Pharmaceutical compositions containing as active principle a 4,5-dihydro-1,3-thiazol-2-ylamine of formula (I) are disclosed, wherein: R represents an -alk-S-alk-Ar, phenyl or phenyl radical substituted with one or more C1-6alkoxy or halogen substituents, and wherein Ar represents a phenyl radical and alk represents a C1-6alkylene radical, or a racemic mixture, an enantiomer or a diastereoisomer thereof or a mixture thereof, or a tautomer thereof or a pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier. These compounds are useful for preventing and treating diseases wherein abnormal production of nitrogen monoxide (NO) by induction of inducible NO- synthase (NOS-2) is involved.
Patent NZ-523175-A (NZ)
Title: Methods of treatment of non-humans using extracts, compounds & pharmaceutical compositions having anti-diabetic activity and in particular the use of steroidal glycosides.
IPC: A61K45/06
Filed: 2001-06-20
Abstract: A method of treating or preventing diabetes in a non-human animal, which comprises administering to the said animal an effective dosage of an extract of a plant of the genus Trichocaulon or of the genus Hoodia. (62) Divided out of 512505
Patent NZ-523998-A (NZ)
Title: 2-aminopyridine compounds and use thereof as drugs
Inventor: HARADA HITOSHI
IPC: A61P25/28
Filed: 2001-08-09
Abstract: A compound of Formula (I), wherein R1 represents cyano group, carboxyl group or an optionally substituted carbamoyl group; R2 represents hydrogen atom, hydroxyl group, an optionally substituted C1-6 alkoxy group, an optionally substituted C6-14 aromatic hydrocarbon cyclic group or an optionally substituted 5- to 14-membered aromatic heterocyclic group; and R3 and R4 are the same as or different from each other and each represents a C3-8 cycloalkyl group, a C3-8 cycloalkenyl group, a C6-14 aromatic hydrocarbon cyclic group, a 5- to 14-membered non-aromatic heterocyclic group or a 5- to 14-membered aromatic heterocyclic group which may have a substituent group, respectively, provided that the cases where (1) R1 is cyano group, R2 is 4-bromo-2-thienyl group, R3 is 3,4- dimethoxyphenyl group and R4 is 2-thienyl group, (2) R1 is cyano group, R2 is hydrogen atom, and each of R3 and R4 is phenyl group, (3) R1 is cyano group, R2 is 4-chlorophenyl group, R3 is phenyl group and R4 is 4-(3,4-dichlorophenyl)- 1-oxo-2(1H)-phthalazinyl group, (4) R1 is cyano group, R2 is hydrogen atom, R3 is 4-pyridyl group and R4 is 1- piperazinyl group, (5) R1 is cyano group, R2 is hydrogen atom, R3 is 4-pyridyl group and R4 is a 1-pyridyl group, (6) R1 is cyano group, R2 is hydrogen atom, R3 is 4-pyridyl group and R4 is 4-diphenylmethyl-1-piperazinyl group, (7) R1 is cyano group, R2 is hydrogen atom, R3 is 4-pyridyl group and R4 is 4-morpholinyl group, (8) R1 is cyano group, R2 is 4- methylphenyl group, and each of R3 and R4 is phenyl group and (9) R1 is cyano group, and each of R2, R3 and R4 is phenyl group are excluded) or a salt thereof; provided that the compound of formula (I) is not 2-arnino-3-cyano-5-(3- methyl-5-isoxazolyl)-6-phenylpyridine or 2-amino-3-cyano-6-phenyl-5-(2-pyridyl)pyridine.